Granules India secures ANDA approval for Pantoprazole Sodium Tablets from FDA

Granules India secures ANDA approval for Pantoprazole Sodium Tablets from FDA

Granules India Limited, a prominent player in the pharmaceutical industry, has announced that the US Food & Drug Administration (US FDA) has approved its Abbreviated New Drug Application (ANDA) for Pantoprazole Sodium Delayed-Release Tablets USP, 20 mg and 40 mg. This approval is a significant milestone for the company, marking its 64th ANDA approval from […]

Lupin Limited launches Turqoz Tablets in US, aims to expand contraceptive market

Lupin Limited launches Turqoz Tablets in US, aims to expand contraceptive market

Global pharmaceutical giant Lupin Limited has made a significant entry into the U.S. contraceptive market with the launch of Turqoz (Norgestrel and Ethinyl Estradiol) Tablets USP, 0.3 mg/0.03 mg. This follows the company’s successful receipt of approval from the United States Food and Drug Administration (U.S. FDA). Turqoz: A Generic Equivalent to Lo/Ovral-28 Turqoz is […]